(-0.02%) 5 186.57 points
(0.39%) 39 035 points
(-0.20%) 16 300 points
(0.98%) $79.15
(-1.18%) $2.18
(-0.15%) $2 320.60
(0.17%) $27.59
(-0.30%) $985.45
(0.12%) $0.931
(0.02%) $10.90
(0.09%) $0.800
(0.34%) $91.75
5 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 0.00%
-1.55% ¥ 4 758.00
Live Chart Being Loaded With Signals
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business...
Stats | |
---|---|
Volumen de hoy | 254 700 |
Volumen promedio | 294 471 |
Capitalización de mercado | 301.49B |
EPS | ¥0 ( 2024-02-08 ) |
Próxima fecha de ganancias | ( ¥83.23 ) 2024-05-13 |
Last Dividend | ¥36.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 14.06 |
ATR14 | ¥2.06 (0.04%) |
Volumen Correlación
Suzuken Co., Ltd. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Suzuken Co., Ltd. Correlación - Moneda/Commodity
Suzuken Co., Ltd. Finanzas
Annual | 2022 |
Ingresos: | ¥2 314.83B |
Beneficio Bruto: | ¥179.70B (7.76 %) |
EPS: | ¥236.46 |
FY | 2022 |
Ingresos: | ¥2 314.83B |
Beneficio Bruto: | ¥179.70B (7.76 %) |
EPS: | ¥236.46 |
FY | 2022 |
Ingresos: | ¥2 232.77B |
Beneficio Bruto: | ¥160.99B (7.21 %) |
EPS: | ¥163.19 |
FY | 2021 |
Ingresos: | ¥2 128.48B |
Beneficio Bruto: | ¥157.84B (7.42 %) |
EPS: | ¥88.52 |
Financial Reports:
No articles found.
Suzuken Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥36.00 (N/A) |
¥0 (N/A) |
¥36.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥9.09 | 2001-03-27 |
Last Dividend | ¥36.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥939.27 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.84 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 2.58 | |
Div. Directional Score | 4.59 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8362.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7743.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6925.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6284.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
4998.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4206.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3407.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2497.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9434.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8086.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0117 | 1.500 | 9.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0212 | 1.200 | 9.29 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0664 | 1.500 | -0.373 | -0.560 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.186 | 0.800 | 9.07 | 7.26 | [1 - 3] |
quickRatioTTM | 0.954 | 0.800 | 9.10 | 7.28 | [0.8 - 2.5] |
cashRatioTTM | 0.206 | 1.500 | 9.97 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 807.19 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0775 | 1.000 | -2.04 | -2.04 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0146 | 1.000 | -1.707 | -1.707 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.818 | 0.800 | 1.213 | 0.970 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.84 | 1.000 | 8.70 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0664 | 2.50 | -0.240 | -0.560 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.692 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -3.58 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00727 | 1.000 | -2.32 | 0 | [0.1 - 0.5] |
Total Score | 2.58 |
Suzuken Co., Ltd.
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico